跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 408 条关于
“CGHD”
全部
408
临床试验
387
药物
11
机构
0
资讯
10
去年
COSCIENS Biopharma Prioritizes Natural Products After Macimorelin Trial Failure
去年
Qurient's Adrixetinib Receives FDA IND Approval for cGVHD Trial
去年
Pimicotinib Shows Promise in Phase 2 Trial for Chronic Graft-versus-Host Disease
去年
Syndax Pharmaceuticals' Niktimvo Approved for cGVHD, Revumenib Awaits FDA Decision
2年前
FDA Approves Niktimvo (axatilimab) for Chronic Graft-versus-Host Disease
去年
Ibrutinib and Rituximab Combination Shows Promise in Chronic Graft-vs-Host Disease
去年
Vir Biotechnology's CHD Treatment Receives FDA Breakthrough Therapy and EMA PRIME Designations
去年
Telemedicine-Based Lifestyle Intervention Shows Limited Benefits for Patients with CHD and Type 2 Diabetes
去年
Prime Medicine Advances Gene Editing Pipeline with Key Programs for CGD, Wilson's Disease, and AATD
去年
Lumos Pharma's Oral LUM-201 Shows Sustained Growth in Pediatric GHD in Phase 2 Trials